Mirvat Alasnag,Lina Yaqoub,Ammar Saati et al.
Mirvat Alasnag et al.
The management of left main coronary artery (LMCA) disease has evolved over the past two decades. Historically, coronary artery bypass grafting (CABG) surgery has been the gold standard for the treatment of LMCA disease. However, with the a...
Tanush Gupta,Michael Weinreich,Mark Greenberg et al.
Tanush Gupta et al.
Rotational atherectomy (RA) is an atheroablative technology that enables percutaneous coronary intervention for complex, calcified coronary lesions. RA works on the principle of 'differential cutting' and preferentially ablates hard, inelas...
Maria Natalia Tovar Forero,Joost Daemen
Maria Natalia Tovar Forero
Calcified lesions often mean percutaneous intervention results are suboptimal and increase the risk of procedural complications and future adverse events. Available plaque-modifying devices rely on tissue compression or debulking, with the ...
Evan Shlofmitz,Allen Jeremias,Richard Shlofmitz et al.
Evan Shlofmitz et al.
Despite significant improvements in stent design, severe coronary calcification continues to impede adequate stent expansion and is associated with worse clinical outcomes. Angiography is limited in its ability to detect and comprehensively...
The Value of Intracoronary Imaging and Coronary Physiology When Treating Calcified Lesions [0.03%]
处理钙化病变时冠脉影像学和生理学的价值评估
Yasushi Ueki,Tatsuhiko Otsuka,Kiyoshi Hibi et al.
Yasushi Ueki et al.
Heavily calcified coronary artery lesions hinder the delivery of devices and limit stent expansion, resulting in low procedural success and poor clinical outcomes driven by an increase in restenosis and stent thrombosis. Intracoronary imagi...
Carlotta Sorini Dini,Giulia Nardi,Francesca Ristalli et al.
Carlotta Sorini Dini et al.
Percutaneous treatment of heavily calcified coronary lesions still represents a challenge for interventional cardiology, with higher risk of immediate complications, late failure due to stent underexpansion and malapposition, and consequent...
Nicolas M Van Mieghem
Nicolas M Van Mieghem
Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation [0.03%]
经导管主动脉瓣植入期间生物心脏瓣膜的瓣膜内瓣膜骨折并发症
John Phineas O&#x;Donnell,Cróchán J O&#x;Sullivan
John Phineas O&#x;Donnell
The limited durability of surgical bioprostheses, combined with an ageing population, has led to an increasing demand for replacing degenerated bioprosthetic surgical heart valves, which is projected to increase. Valve-in-valve transcathete...
Magdalena Erlebach,Rüdiger Lange
Magdalena Erlebach
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve diseas...
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes [0.03%]
经导管主动脉瓣植入术中的性别差异：女性患者的临床预后分析
Alessandra Laricchia,Barbara Bellini,Vittorio Romano et al.
Alessandra Laricchia et al.
Transcatheter aortic valve implantation (TAVI) has emerged as an alternative treatment for severe symptomatic aortic stenosis in patients who are not suitable for surgery or are at high surgical risk. Approximately 50% of patients undergoin...